视觉模拟量表与扩展前列腺癌指数综合-26在三维腹腔镜根治性前列腺切除术后尿控恢复评估中的研究:单中心前瞻性注册研究
该单中心前瞻性注册研究纳入105例在芬兰塞伊奈约基中央医院接受三维腹腔镜根治性前列腺切除术的男性,术前及术后多个时间点使用视觉模拟量表(VAS)和扩展前列腺癌指数综合(EPIC)-26评估尿控恢复。结果显示尿控在术后第一年内显著改善,此后不再改善;VAS与EPIC-26尿失禁域评分在术前、12个月和24个月的相关系数分别为0.639、0.807和0.831(P < 0.001)。结论认为VAS可作为EPIC-26的简易替代工具用于评估术后尿控恢复。
要点
- 术后第一年内尿控显著改善,此后不再改善。
- VAS与EPIC-26尿失禁域评分的相关性随时间增强,24个月时相关系数为0.831。
- VAS可作为EPIC-26的简易替代工具评估三维腹腔镜根治性前列腺切除术后尿控恢复。
核心结论
- VAS可作为EPIC-26的简易替代工具用于评估三维腹腔镜根治性前列腺切除术后尿控恢复。
研究设计与样本
- 单中心前瞻性注册研究,纳入2018年11月至2021年2月在芬兰塞伊奈约基中央医院接受三维腹腔镜根治性前列腺切除术的105例男性。
主要发现
- 共有915份VAS表格和909份EPIC-26问卷可评估。
- 尿控在术后第一年内显著改善,此后不再改善。
- UI-EPIC-26中位数在3个月为50.8(0-100)、12个月为76.8(14.5-100)、24个月为79.6(8.25-100)。
- VAS中位数在3个月为7.2 cm(0-10 cm)、12个月为8.7 cm(1.7-10 cm)、24个月为9.0 cm(2.7-10 cm)。
- VAS与UI-EPIC-26的相关系数在术前为0.639(95%CI 0.505-0.743)、12个月为0.807(95%CI 0.716-0.871)、24个月为0.831(95%CI 0.735-0.894),均P < 0.001。
临床怎么用
- 原文结论认为VAS可作为EPIC-26的简易替代工具用于评估三维腹腔镜根治性前列腺切除术后尿控恢复。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the correlation between the Visual Analogue Scale (VAS) and the Expanded Prostate Cancer Index Composite (EPIC)-26 in the evaluation of urinary continence (UC) recovery after 3-dimensional laparoscopic radical prostatectomy (3D-LRP). METHODS: 105 men underwent 3D-LRP in Seinäjoki Central Hospital Finland between November 2018 and February 2021. VAS forms and EPIC-26 questionnaires were used to assess UC preoperatively and at 6 weeks, 3-, 6-, 9-, 12-, 15-, 18-, 21-, and 24 months postoperatively. On the VAS form, the patient put a mark on the 10 cm long horizontal line in place, which described his experienced degree of UC (0 cm; fully incontinent-10 cm; fully continent). The scores for the urinary incontinence domain of EPIC-26 (UI-EPIC-26) were calculated and transformed to a scale of 0-100. Spearman´s rank correlation coefficient was used to evaluate the correlation between the VAS and UI-EPIC-26. RESULTS: A total of 915 VAS forms and 909 EPIC-26 questionnaires were evaluable. UC improved significantly during the first year but not after that. The medians for UI-EPIC-26 and VAS were 50.8 (0-100) and 7.2 cm (0-10 cm) at 3 months, 76.8 (14.5-100) and 8.7 cm (1.7-10 cm) at 12 months and 79.6 (8.25-100) and 9.0 cm (2.7-10 cm) at 24 months. The correlation coefficient (95% confidence interval) between VAS and UI-EPIC-26 preoperatively, at 12 months and at 24 months was 0.639 (0.505-0.743), 0.807 (0.716-0.871), and 0.831 (0.735-0.894), respectively (P < 0.001). CONCLUSION: The VAS can be utilized as an easy-to-use alternative to the EPIC-26 when evaluating UC recovery after 3D-LRP.
引用
- Valli J, Haapiainen H, Murtola TJ, et al. Visual Analogue Scale and Expanded Prostate Cancer Index Composite-26 in the Evaluation of Urinary Continence Recovery After Three-Dimensional Laparoscopic Radical Prostatectomy, a Single-Center Prospective Registered Study. Urology. 2023. PMID: 37146729. doi:10.1016/j.urology.2023.04.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。